Verapamil for severe hyperkinetic movement disorders
Identifieur interne : 003723 ( Istex/Corpus ); précédent : 003722; suivant : 003724Verapamil for severe hyperkinetic movement disorders
Auteurs : Ovsiew ; Kimford J. Meador ; Kapil SethiSource :
- Movement Disorders [ 0885-3185 ] ; 1998-03.
English descriptors
Abstract
The use of verapamil in three cases of severe hyperkinetic movement disorders resulted in dramatic improvement in patients who had been refractory to many other treatments over a prolonged period. A videotape illustration of one of the patients is provided. The mechanism of action and evidence of efficacy of calcium‐channel blockers for abnormal movements are discussed.
Url:
DOI: 10.1002/mds.870130224
Links to Exploration step
ISTEX:B88428F68E77C9AFF77EACBE81F511A9F5D99294Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Verapamil for severe hyperkinetic movement disorders</title><author><name sortKey="Ovsiew" sort="Ovsiew" uniqKey="Ovsiew" last="Ovsiew">Ovsiew</name><affiliation><mods:affiliation>University of Chicago, Chicago, Illinois</mods:affiliation></affiliation></author><author><name sortKey="Meador, Kimford J" sort="Meador, Kimford J" uniqKey="Meador K" first="Kimford J." last="Meador">Kimford J. Meador</name><affiliation><mods:affiliation>Medical College of Georgia, Augusta, Georgia, U.S.A</mods:affiliation></affiliation></author><author><name sortKey="Sethi, Kapil" sort="Sethi, Kapil" uniqKey="Sethi K" first="Kapil" last="Sethi">Kapil Sethi</name><affiliation><mods:affiliation>Medical College of Georgia, Augusta, Georgia, U.S.A</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:B88428F68E77C9AFF77EACBE81F511A9F5D99294</idno><date when="1998" year="1998">1998</date><idno type="doi">10.1002/mds.870130224</idno><idno type="url">https://api.istex.fr/document/B88428F68E77C9AFF77EACBE81F511A9F5D99294/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003723</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Verapamil for severe hyperkinetic movement disorders</title><author><name sortKey="Ovsiew" sort="Ovsiew" uniqKey="Ovsiew" last="Ovsiew">Ovsiew</name><affiliation><mods:affiliation>University of Chicago, Chicago, Illinois</mods:affiliation></affiliation></author><author><name sortKey="Meador, Kimford J" sort="Meador, Kimford J" uniqKey="Meador K" first="Kimford J." last="Meador">Kimford J. Meador</name><affiliation><mods:affiliation>Medical College of Georgia, Augusta, Georgia, U.S.A</mods:affiliation></affiliation></author><author><name sortKey="Sethi, Kapil" sort="Sethi, Kapil" uniqKey="Sethi K" first="Kapil" last="Sethi">Kapil Sethi</name><affiliation><mods:affiliation>Medical College of Georgia, Augusta, Georgia, U.S.A</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1998-03">1998-03</date><biblScope unit="vol">13</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="341">341</biblScope><biblScope unit="page" to="344">344</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">B88428F68E77C9AFF77EACBE81F511A9F5D99294</idno><idno type="DOI">10.1002/mds.870130224</idno><idno type="ArticleID">MDS870130224</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Calcium channel blockers</term><term>Hyperkinetic movement disorders</term><term>Tardive dyskinesia</term><term>Verapamil</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The use of verapamil in three cases of severe hyperkinetic movement disorders resulted in dramatic improvement in patients who had been refractory to many other treatments over a prolonged period. A videotape illustration of one of the patients is provided. The mechanism of action and evidence of efficacy of calcium‐channel blockers for abnormal movements are discussed.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Dr. Ovsiew MD</name><affiliations><json:string>University of Chicago, Chicago, Illinois</json:string></affiliations></json:item><json:item><name>Kimford J. Meador MD</name><affiliations><json:string>Medical College of Georgia, Augusta, Georgia, U.S.A</json:string></affiliations></json:item><json:item><name>Kapil Sethi MD</name><affiliations><json:string>Medical College of Georgia, Augusta, Georgia, U.S.A</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Calcium channel blockers</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Verapamil</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Tardive dyskinesia</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Hyperkinetic movement disorders</value></json:item></subject><language><json:string>eng</json:string></language><abstract>The use of verapamil in three cases of severe hyperkinetic movement disorders resulted in dramatic improvement in patients who had been refractory to many other treatments over a prolonged period. A videotape illustration of one of the patients is provided. The mechanism of action and evidence of efficacy of calcium‐channel blockers for abnormal movements are discussed.</abstract><qualityIndicators><score>2.836</score><pdfVersion>1.3</pdfVersion><pdfPageSize>612 x 792 pts (letter)</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>372</abstractCharCount><pdfWordCount>2164</pdfWordCount><pdfCharCount>13847</pdfCharCount><pdfPageCount>4</pdfPageCount><abstractWordCount>56</abstractWordCount></qualityIndicators><title>Verapamil for severe hyperkinetic movement disorders</title><genre><json:string>Serial article</json:string></genre><host><volume>13</volume><pages><total>4</total><last>344</last><first>341</first></pages><issn><json:string>0885-3185</json:string></issn><issue>2</issue><subject><json:item><value>Brief Report</value></json:item></subject><genre></genre><language><json:string>unknown</json:string></language><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>1998</publicationDate><copyrightDate>1998</copyrightDate><doi><json:string>10.1002/mds.870130224</json:string></doi><id>B88428F68E77C9AFF77EACBE81F511A9F5D99294</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/B88428F68E77C9AFF77EACBE81F511A9F5D99294/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/B88428F68E77C9AFF77EACBE81F511A9F5D99294/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/B88428F68E77C9AFF77EACBE81F511A9F5D99294/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Verapamil for severe hyperkinetic movement disorders</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>Wiley Subscription Services, Inc., A Wiley Company</p></availability><date>1998</date></publicationStmt><notesStmt><note type="content">*A videotape accompanies this article</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Verapamil for severe hyperkinetic movement disorders</title><author><persName><surname>Ovsiew</surname><roleName type="degree">Dr.</roleName></persName><note type="correspondence"><p>Correspondence: Department of Psychiatry MC 3077, University of Chicago Hospitals, 5841 South Maryland, Chicago, IL 60637, U.S.A</p></note><affiliation>University of Chicago, Chicago, Illinois</affiliation></author><author><persName><forename type="first">Kimford J.</forename><surname>Meador</surname><roleName type="degree">MD</roleName></persName><affiliation>Medical College of Georgia, Augusta, Georgia, U.S.A</affiliation></author><author><persName><forename type="first">Kapil</forename><surname>Sethi</surname><roleName type="degree">MD</roleName></persName><affiliation>Medical College of Georgia, Augusta, Georgia, U.S.A</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1998-03"></date><biblScope unit="vol">13</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="341">341</biblScope><biblScope unit="page" to="344">344</biblScope></imprint></monogr><idno type="istex">B88428F68E77C9AFF77EACBE81F511A9F5D99294</idno><idno type="DOI">10.1002/mds.870130224</idno><idno type="ArticleID">MDS870130224</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1998</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>The use of verapamil in three cases of severe hyperkinetic movement disorders resulted in dramatic improvement in patients who had been refractory to many other treatments over a prolonged period. A videotape illustration of one of the patients is provided. The mechanism of action and evidence of efficacy of calcium‐channel blockers for abnormal movements are discussed.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Calcium channel blockers</term></item><item><term>Verapamil</term></item><item><term>Tardive dyskinesia</term></item><item><term>Hyperkinetic movement disorders</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>Article category</head><item><term>Brief Report</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1997-04-14">Received</change><change when="1997-07-18">Registration</change><change when="1998-03">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/B88428F68E77C9AFF77EACBE81F511A9F5D99294/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="tocForm">Movement Disorders</title><title type="subtitle">Official Journal of the Movement Disorder Society</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="20"><doi origin="wiley" registered="yes">10.1002/mds.v13:2</doi><numberingGroup><numbering type="journalVolume" number="13">13</numbering><numbering type="journalIssue">2</numbering></numberingGroup><coverDate startDate="1998-03">March 1998</coverDate></publicationMeta><publicationMeta level="unit" type="shortCommunication" position="24" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.870130224</doi><idGroup><id type="unit" value="MDS870130224"></id></idGroup><countGroup><count type="pageTotal" number="4"></count></countGroup><titleGroup><title type="articleCategory">Brief Report</title><title type="tocHeading1">Brief Reports</title></titleGroup><copyright ownership="thirdParty">Copyright © 1998 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="1997-04-14"></event><event type="manuscriptRevised" date="1997-07-17"></event><event type="manuscriptAccepted" date="1997-07-18"></event><event type="firstOnline" date="2004-11-04"></event><event type="publishedOnlineFinalForm" date="2004-11-04"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:HeaderRef result:HeaderRef" date="2010-03-09"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">341</numbering><numbering type="pageLast">344</numbering></numberingGroup><correspondenceTo>Department of Psychiatry MC 3077, University of Chicago Hospitals, 5841 South Maryland, Chicago, IL 60637, U.S.A</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS870130224.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="1"></count><count type="tableTotal" number="0"></count><count type="referenceTotal" number="24"></count></countGroup><titleGroup><title type="main" xml:lang="en">Verapamil for severe hyperkinetic movement disorders<link href="#fn1"></link></title><title type="short" xml:lang="en">VERAPAMIL FOR HYPERKINETIC MOVEMENT DISORDERS</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><honorifics>Dr.</honorifics><givenNames>Fred</givenNames><familyName>Ovsiew</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Kimford J.</givenNames><familyName>Meador</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Kapil</givenNames><familyName>Sethi</familyName><degrees>MD</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="US" type="organization"><unparsedAffiliation>University of Chicago, Chicago, Illinois</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="US" type="organization"><unparsedAffiliation>Medical College of Georgia, Augusta, Georgia, U.S.A</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Calcium channel blockers</keyword><keyword xml:id="kwd2">Verapamil</keyword><keyword xml:id="kwd3">Tardive dyskinesia</keyword><keyword xml:id="kwd4">Hyperkinetic movement disorders</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>The use of verapamil in three cases of severe hyperkinetic movement disorders resulted in dramatic improvement in patients who had been refractory to many other treatments over a prolonged period. A videotape illustration of one of the patients is provided. The mechanism of action and evidence of efficacy of calcium‐channel blockers for abnormal movements are discussed.</p></abstract></abstractGroup></contentMeta><noteGroup><note xml:id="fn1"><p>A videotape accompanies this article</p></note></noteGroup></header></component></istex:document></istex:metadataXml><!--Version 0.6 générée le 4-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Verapamil for severe hyperkinetic movement disorders</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>VERAPAMIL FOR HYPERKINETIC MOVEMENT DISORDERS</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Verapamil for severe hyperkinetic movement disorders</title></titleInfo><name type="personal"><namePart type="termsOfAddress">Dr.</namePart><namePart type="family">Ovsiew</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>University of Chicago, Chicago, Illinois</affiliation><description>Correspondence: Department of Psychiatry MC 3077, University of Chicago Hospitals, 5841 South Maryland, Chicago, IL 60637, U.S.A</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Kimford J.</namePart><namePart type="family">Meador</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Medical College of Georgia, Augusta, Georgia, U.S.A</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Kapil</namePart><namePart type="family">Sethi</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Medical College of Georgia, Augusta, Georgia, U.S.A</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre authority="originalCategForm">shortCommunication</genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">1998-03</dateIssued><dateCaptured encoding="w3cdtf">1997-04-14</dateCaptured><dateValid encoding="w3cdtf">1997-07-18</dateValid><copyrightDate encoding="w3cdtf">1998</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">1</extent><extent unit="references">24</extent></physicalDescription><abstract lang="en">The use of verapamil in three cases of severe hyperkinetic movement disorders resulted in dramatic improvement in patients who had been refractory to many other treatments over a prolonged period. A videotape illustration of one of the patients is provided. The mechanism of action and evidence of efficacy of calcium‐channel blockers for abnormal movements are discussed.</abstract><note type="content">*A videotape accompanies this article</note><subject lang="en"><genre>Keywords</genre><topic>Calcium channel blockers</topic><topic>Verapamil</topic><topic>Tardive dyskinesia</topic><topic>Hyperkinetic movement disorders</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title><subTitle>Official Journal of the Movement Disorder Society</subTitle></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><subject><genre>article category</genre><topic>Brief Report</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><detail type="issue"><caption>no.</caption><number>2</number></detail><extent unit="pages"><start>341</start><end>344</end><total>4</total></extent></part></relatedItem><identifier type="istex">B88428F68E77C9AFF77EACBE81F511A9F5D99294</identifier><identifier type="DOI">10.1002/mds.870130224</identifier><identifier type="ArticleID">MDS870130224</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 1998 Movement Disorder Society</accessCondition><recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003723 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 003723 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:B88428F68E77C9AFF77EACBE81F511A9F5D99294
|texte= Verapamil for severe hyperkinetic movement disorders
}}
| This area was generated with Dilib version V0.6.23. |  |